SBIR/STTR Research Award

Novel Bioabsorbable, Flexible Polymeric Stent for Pulmonary Artery Stenosis

Award identifier 7f99084ab2b687c8641e7fe7cc546dc3fb134c32587a1dee7e150c9655584d9bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$2,860,961

Program and phase

SBIR · Phase II

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Lyra Therapeutics, Inc.
Proposal award date
2016-08-01
Contract end date
2019-07-31
UEI
DK48JGAVNMJ1
Solicitation number
HL14-012
Topic code
NHLBI

Research abstract

DESCRIPTIONprovided by applicantSignificancePediatric patients with pulmonary artery stenosis face treatment options with significant limitationsFor examplemetal stents are limited by long term interference with natural vessel growthPatients implanted with metal stents are subject to multiple hospital admissions for interventional stent expansionsoften requiring fracture of the stent and openheart surgery for removalAs suchthere is an emergent need for pediatric specific devices for this underserved populationApproachIn response to a solicitation from NHLBIBiomedical developed a selfexpandingbioresorbable stent to treat pulmonary artery stenosis under a Fast Track SBIRThrough the Fast Track projectpromising animal results were achieved through the device resorption periodwhile in growing vesselsOn the strength of these Fast Track datawe raised $M of funding from Broadview VenturesThis Phase IIB SBIR application will enable advancement of this product towards commercialization applicationIn this projectfirst inhuman experience with this innovative device will be achievedDuring Yearcurrent bench and animal data will be supplemented to create a data package to enable submission of an Investigational Device ExemptionIDEfor an Early Feasibility StudyEFSThis accomplishment will enable enrollment of clinical subjects during YearYearwill be focused onmo follow up in the EFSand along with an extensive package of bench and pre clinical datathis human data will be submitted to the FDA for marketing clearanceThis project represents an important step in the commercialization of a therapy that has the potential to be a game changer for pediatric patients with pulmonary artery stenosisInnovationBiomedical s novel stent couples full bioresorption with self expansiontwo features that are ideal for the pediatric populationThis combination of properties is achieved through our unique composite designBy utilizing a strong base braid coated with a proprietary elastomerwe can achieve properties that are similar to metal in a fully resorbable designThe self expansion of this design provides the added benefit of enabling the stent to maintain apposition with the vessel wall as a pediatric patient growsThe fastyet saferesorption characteristics of the design will enable the device to "grow" with the vessel without impeding early interventionif required

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

4 SBIR/STTR records share this UEI (2015–2018). Reported award amounts total $6,768,961. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.